Society of Cardiovascular Angiography and intervention Stage-B cardiogenic shock: An interventional-heart

Aryan Mehta1, Mridul Bansal1, Peter Matthew Belford1

  • 1Section of Cardiovascular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.

IHJ Cardiovascular Case Reports
|October 25, 2024
PubMed

Insights

The Society of Cardiovascular Angiography and Intervention (SCAI) classified cardiogenic shock (CS) into five stages. This study examines the ambiguous Stage B of cardiogenic shock, highlighting the need for prompt interventions in managing this critical condition.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • The Society of Cardiovascular Angiography and Intervention (SCAI) developed a five-stage classification for cardiogenic shock (CS), ranging from A to E.
  • SCAI Stage B represents a critical phase in cardiogenic shock with significant ambiguity in its assessment and management.
  • The nebulous nature of Stage B CS poses a risk of rapid escalation, necessitating timely and effective interventions.

Purpose of the Study:

  • To describe the clinical trajectory of patients presenting with SCAI Stage B cardiogenic shock.
  • To provide insights into the assessment and management challenges associated with SCAI Stage B CS.
  • To emphasize the urgency of interventions for patients in SCAI Stage B CS.

Main Methods:

  • Retrospective analysis of cases presenting with SCAI Stage B cardiogenic shock.
  • Description of patient pathways and clinical outcomes.
  • Review of management strategies employed for Stage B CS.

Main Results:

  • Characterization of the typical progression of SCAI Stage B CS.
  • Identification of key factors influencing patient outcomes.
  • Analysis of the effectiveness of different intervention strategies.

Conclusions:

  • SCAI Stage B cardiogenic shock requires careful monitoring and prompt management due to its potential for rapid deterioration.
  • Further research is needed to refine the assessment and treatment protocols for Stage B CS.
  • Understanding the trajectory of Stage B CS is crucial for improving patient survival and outcomes.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
1
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1